AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Resmed DRC

37.260

+0.3600.98%

Volume:534.78K

Turnover:19.89M

Market Cap:54.63B

PE:29.11

High:37.320

Open:36.850

Low:36.720

Close:36.900

Loading ...

Overview Company News Filings

ResMed Inc. Stock Outperforms Market Despite Losses On The Day

ResMed Inc. Stock Rises Monday, Still Underperforms Market

5 reasons to buy these ASX shares after the market sell-off

5 quality ASX shares for beginners to buy

Impact investing with Fortescue shares

Top broker says these ASX 200 stocks are buys following the market selloff

New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer

How to navigate the Trump Slump?

ResMed Inc. Stock Falls Tuesday, Underperforms Market

How investing in ASX shares can transform your financial future

ResMed Inc. Stock Rises Friday, Still Underperforms Market

How to invest like Warren Buffett with ASX shares in 2025

The Zacks Analyst Blog Highlights NVIDIA, Resmed, GE HealthCare and Medtronic

The ASX growth companies primed for a big year

Should you buy this top ASX share in the dip?

Resmed to Consolidate Portfolio into One Brand; Shares Fall 5%

MT Newswires Live

These top ASX shares could rise 35% to 70%

BUZZ-Resmed's Australian shares fall after insider Ghoshal sells stock

Why Breville, Flight Centre, Orica, and ResMed shares are dropping today

Resmed Chief Commercial Officer Offloads $2.3 Million Worth of Shares

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RMD.AU/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RMD.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RMD.AU\",,,,,undefined,":{"symbol":"RMD.AU","market":"AU","secType":"STK","nameCN":"Resmed DRC","latestPrice":37.26,"timestamp":1746166320000,"preClose":36.9,"halted":0,"volume":534783,"delay":0,"nameEN":"Resmed DRC","floatShares":145691036,"shares":1466188140,"eps":1.2798634812286689,"marketStatus":"Market Closed","change":0.36,"latestTime":"05-02 16:12:00 AEST","open":36.85,"high":37.32,"low":36.72,"amount":19886061,"amplitude":0.01626,"askPrice":37.29,"askSize":26,"bidPrice":37.07,"bidSize":580,"shortable":3,"etf":0,"ttmEps":1.2798634812286689,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1746403200000},"marketStatusCode":7,"adr":0,"adrRate":1,"exchange":"ASX","adjPreClose":36.9,"dividendRate":0.008202,"openAndCloseTimeList":[[1746144000000,1746165600000]],"volumeRatio":0.25883601211665325,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RMD.AU\",,,,,undefined,":{"symbol":"RMD.AU","floatShares":145691036,"roa":"14.01%","roe":"25.81%","lyrEps":0.969594,"volumeRatio":0.25883601211665325,"shares":1466188140,"dividePrice":0.305616,"high":37.32,"amplitude":0.01626,"preClose":36.9,"low":36.72,"week52Low":26.946,"pbRate":"6.35","psRate":"7.01","week52High":40.661,"institutionHeld":0,"latestPrice":37.26,"committee":0.914191,"eps":1.2798634812286689,"divideRate":0.008202,"volume":534783,"delay":0,"ttmEps":1.2798634812286689,"open":36.85,"prevYearClose":36.689,"prevWeekClose":36.08,"prevMonthClose":36.68,"prevQuarterClose":34.96,"fiveDayClose":36.08,"twentyDayClose":35.63,"sixtyDayClose":38.874},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RMD.AU\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2523635648","title":"ResMed Inc. Stock Outperforms Market Despite Losses On The Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2523635648","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523635648?lang=en_us&edition=fundamental","pubTime":"2025-03-29 04:56","pubTimestamp":1743195360,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of ResMed Inc.  slipped 1.20% to $219.94 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 1.97% to 5,580.94 and Dow Jones Industrial Average  falling 1.69% to 41,583.90.The stock's fall snapped a two-day winning streak.ResMed Inc. closed 16.39% below its 52-week high of $263.05, which the company achieved on January 30th.Trading volume  remained 452,272 below its 50-day average volume of 994,659.Data source: Dow Jones Market Data, FactSet. Data compiled March 28, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RMD.AU","RMD"],"gpt_icon":0},{"id":"2522088448","title":"ResMed Inc. Stock Rises Monday, Still Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2522088448","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522088448?lang=en_us&edition=fundamental","pubTime":"2025-03-25 04:56","pubTimestamp":1742849760,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of ResMed Inc.  rose 1.46% to $222.91 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 1.76% to 5,767.57 and the Dow Jones Industrial Average  rising 1.42% to 42,583.32.The stock's rise snapped a two-day losing streak.ResMed Inc. closed 15.26% short of its 52-week high of $263.05, which the company reached on January 30th.Trading volume  remained 249,040 below its 50-day average volume of 1.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled March 24, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RMD","RMD.AU"],"gpt_icon":0},{"id":"2521731514","title":"5 reasons to buy these ASX shares after the market sell-off","url":"https://stock-news.laohu8.com/highlight/detail?id=2521731514","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521731514?lang=en_us&edition=fundamental","pubTime":"2025-03-24 07:56","pubTimestamp":1742774183,"startTime":"0","endTime":"0","summary":"After a market selloff, many investors feel uneasy about diving back in. But history has shown that periods of market weakness often present some of the best buying opportunities. Rather than fearing ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/03/24/5-reasons-to-buy-these-asx-shares-after-the-market-selloff/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK4504","WTC.AU","LU2471134523.USD","BK4550","LU2271345857.HKD","IE00B19Z3B42.SGD","LU1868837136.USD","LU0971096721.USD","LU2237443622.USD","IE00BKVL7J92.USD","LU2237443978.SGD","LU1720051017.SGD","LU2133065610.SGD","BK7040","LU0098860793.USD","LU2089283258.USD","EDV.AU","LU2357305700.SGD","IE00BSNM7G36.USD","LU1732800096.USD","BK4516","BK7016","LU0061475181.USD","LU2471134796.USD","IE0002270589.USD","BK4588","LU1363072403.SGD","LU2089284900.SGD","LU0795875086.SGD","LU2750360641.GBP","LU1720051108.HKD","IE0004086264.USD","BK7503","LU2750360997.AUD","BK7007","LU0096364046.USD","LU1791807156.HKD","LU2237438978.USD","IE00BFXG1179.USD","LU1074936037.SGD","LU0158827781.USD","LU1989772840.SGD","BK4581","LU0006306889.USD","LU1162221912.USD","LU1989772923.USD","BK4127","RMD.AU","LU1732799900.SGD","LU2471134952.CNY"],"gpt_icon":0},{"id":"2521241715","title":"5 quality ASX shares for beginners to buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2521241715","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521241715?lang=en_us&edition=fundamental","pubTime":"2025-03-23 03:50","pubTimestamp":1742673000,"startTime":"0","endTime":"0","summary":"Investing in the stock market can be intimidating for beginners. Do you chase speculative stocks that promise quick riches, or do you get rich slowly?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/03/23/5-quality-asx-shares-for-beginners-to-buy/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["LU2065171402.SGD","IE0004445239.USD","LU2125154935.USD","LU1914381329.SGD","LU2211815571.USD","SG9999001077.SGD","LU0708994859.HKD","LU2023251221.USD","LU2087625088.SGD","LU0080751232.USD","LU1316542783.SGD","LU0354030511.USD","REA.AU","GB00BDT5M118.USD","IE00B3SWFQ91.USD","IE00B4JS1V06.HKD","BK4561","TAM.AU","IE0034235188.USD","LU0642271901.SGD","BK4534","LU0077335932.USD","LU0061475181.USD","LU0198837287.USD","USAW.SI","SG9999018865.SGD","LU0957791311.USD","LU1861127337.USD","LU1935043536.SGD","LU0079474960.USD","SG9999014898.SGD","TLS.AU","LU0053666078.USD","LU0097036916.USD","XRO.AU","LU1084165304.USD","LU1037948897.HKD","IE00BK4W5M84.HKD","IE00B19Z9505.USD","GMG.AU","LU2361044865.SGD","LU0098860793.USD","SG9999002232.USD","BK4598","LU0006306889.USD","LU0640476718.USD","BK7007","LU2360106780.USD","RMD.AU"],"gpt_icon":1},{"id":"2521419569","title":"Impact investing with Fortescue shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2521419569","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521419569?lang=en_us&edition=fundamental","pubTime":"2025-03-21 06:30","pubTimestamp":1742509800,"startTime":"0","endTime":"0","summary":"Last week, an article I wrote on Fortescue Ltd  caught the attention of a potential investor who reached out to me with an interesting question. The article highlighted how the Fortescue share price had plunged around 40% over the past year and could now represent a good buying opportunity. But the investor had concerns beyond the company's ability to deliver returns. She questioned: \"How can I invest in a mining company when I don't approve of their impact on the environment?\" The answer could be simple: 'You can't, so don't invest in Fortescue shares'. However, the question deserves a better answer than that and opens the door to exploring ethical investment options on the ASX. Can mining shares offer ethical investments?","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/03/21/impact-investing-with-fortescue-shares/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["MQG.AU","BK7129","BK7095","COH.AU","AEF.AU","BK7504","BK7067","XKO.AU","XAO.AU","BK7062","BK7511","WBC.AU","NAB.AU","BK7135","FMG.AU","PLS.AU","BK7501","RMD.AU","BK7046","BK7139","BOQ.AU","CSL.AU","BK7508","XJO.AU","ESG","BK7507","BK7007"],"gpt_icon":0},{"id":"2520458723","title":"Top broker says these ASX 200 stocks are buys following the market selloff","url":"https://stock-news.laohu8.com/highlight/detail?id=2520458723","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520458723?lang=en_us&edition=fundamental","pubTime":"2025-03-20 11:00","pubTimestamp":1742439600,"startTime":"0","endTime":"0","summary":"Now could be an opportune time to load up on some quality ASX 200 stocks according to one top broker. According to a note out of Wilsons, its analysts believe that the recent market selloff has create","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/03/20/top-broker-says-these-asx-200-stocks-are-buys-following-the-market-selloff/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7099","CTO.AU","RMD.AU","BK7007","BK7503","BK7016","BK7510","BK7155","CTO","BK7501","BK7104","GMG.AU","WTC.AU","BK4160"],"gpt_icon":1},{"id":"2520183509","title":"New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer","url":"https://stock-news.laohu8.com/highlight/detail?id=2520183509","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520183509?lang=en_us&edition=fundamental","pubTime":"2025-03-19 20:00","pubTimestamp":1742385600,"startTime":"0","endTime":"0","summary":"Largest ever meta-analysis on the long-term benefits of CPAP therapy, published in The Lancet Respiratory Medicine, found that in people with sleep apnea, CPAP therapy lowered the overall chance of dying by 37% and the chance of heart-related death by 55%.The study, led by global experts in sleep and respiratory medicine and supported by Resmed, found that people with OSA who use CPAP therapy have:. A 37% lower risk of dying from any cause compared to those with OSA who do not use CPAP.\"The results of the study strongly suggest that CPAP therapy is a life-saving intervention for people with OSA,” said Atul Malhotra, M.D, senior author of the study, Research Chief of Pulmon","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/global-study-finds-sleep-apnea-120000929.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","BK4082","RMD.AU","RMD","LU2177674079.SGD","LU2008162690.USD","BK4567","BK4585","BK4504","BK4548"],"gpt_icon":1},{"id":"2520193869","title":"How to navigate the Trump Slump?","url":"https://stock-news.laohu8.com/highlight/detail?id=2520193869","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520193869?lang=en_us&edition=fundamental","pubTime":"2025-03-19 12:06","pubTimestamp":1742357215,"startTime":"0","endTime":"0","summary":"Financial markets are now, broadly measured, divided into two categories of people, as is in fact the global population, including those who do not actively invest:. -those who look at events unfolding from the perspective that nothing fundamentally has changed, waiting for 'old' dynamics to re-assert themselves in due course. -those who instinctively, or otherwise, sense things are changing, but there are no answers yet available as to what exactly the end outcome might be. The division between these two groups of people is nothing new. This happens every time financial markets change direction and composure. It's human nature to stick to the familiar script and view the world through an unchanged lens long after the facts have fundamentally changed.One mistake investors on Wall Street, and elsewhere, have made is to solely concentrate on the pro-business policies this freshly installed Trump 2.0 administration embodies. Less red tape and lower taxes equals higher share prices, right?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/how-to-navigate-the-trump-slump","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/how-to-navigate-the-trump-slump","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["WES","BK7031","PME.AU","SGH.AU","BK4022","BK4585","JBH.AU","WES.AU","HUB.AU","BK7129","BK4548","BK7062","BSL","TNE.AU","MQG.AU","BK7001","LU1571399168.USD","GPT.AU","ALL","PME","ETF.AU","WOW.AU","BK7087","NWL.AU","LU2177674079.SGD","CHC.AU","BK7153","BSL.AU","BK7503","CAR.AU","COL.AU","BK7082","BK7046","GMG.AU","CAR","RMD.AU","XRO.AU","BK4588","BK7041","BK4590","BK4180","NWL","BK7040","RMD","BK7511","ALL.AU","BK7016","IEL.AU","BK4567","WOW"],"gpt_icon":0},{"id":"2520937751","title":"ResMed Inc. Stock Falls Tuesday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2520937751","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520937751?lang=en_us&edition=fundamental","pubTime":"2025-03-19 04:57","pubTimestamp":1742331420,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of ResMed Inc.  shed 2.00% to $220.25 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 1.07% to 5,614.66 and Dow Jones Industrial Average  falling 0.62% to 41,581.31.The stock's fall snapped a two-day winning streak.ResMed Inc. closed 16.27% short of its 52-week high of $263.05, which the company reached on January 30th.Trading volume  remained 278,400 below its 50-day average volume of 988,955.Data source: Dow Jones Market Data, FactSet. Data compiled March 18, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RMD.AU","RMD"],"gpt_icon":0},{"id":"2519352146","title":"How investing in ASX shares can transform your financial future","url":"https://stock-news.laohu8.com/highlight/detail?id=2519352146","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519352146?lang=en_us&edition=fundamental","pubTime":"2025-03-15 07:34","pubTimestamp":1741995240,"startTime":"0","endTime":"0","summary":"For many Australians, financial security and wealth creation can seem like a distant dream. But the truth is, with a combination of patience, discipline, and a well-planned investment strategy, anyone","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/03/15/how-investing-in-asx-shares-can-transform-your-financial-future/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7503","XKO.AU","MQG.AU","BK7511","BK7067","BK7016","BK7501","BK7099","BK7046","BK7510","XRO.AU","XAO.AU","GMG.AU","CSL.AU","XJO.AU","BK7007","BK7508","BK7155","RMD.AU"],"gpt_icon":1},{"id":"2519309613","title":"ResMed Inc. Stock Rises Friday, Still Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2519309613","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519309613?lang=en_us&edition=fundamental","pubTime":"2025-03-15 04:55","pubTimestamp":1741985700,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of ResMed Inc.  rose 2.02% to $224.16 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 2.13% to 5,638.94 and the Dow Jones Industrial Average  rising 1.65% to 41,488.19.The stock's rise snapped a three-day losing streak.ResMed Inc. closed 14.78% below its 52-week high of $263.05, which the company achieved on January 30th.Trading volume  remained 231,509 below its 50-day average volume of 978,432.Data source: Dow Jones Market Data, FactSet. Data compiled March 14, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RMD","RMD.AU"],"gpt_icon":0},{"id":"2519356778","title":"How to invest like Warren Buffett with ASX shares in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2519356778","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519356778?lang=en_us&edition=fundamental","pubTime":"2025-03-15 03:34","pubTimestamp":1741980840,"startTime":"0","endTime":"0","summary":"Warren Buffett is widely regarded as one of the greatest investors of all time. Over the past six decades, the Oracle of Omaha has built Berkshire Hathaway (NYSE: BRK.A) into a trillion-dollar empire ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/03/15/how-to-invest-like-warren-buffett-with-asx-shares-in-2025/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BRK.A","IE000M9KFDE8.USD","LU1074936037.SGD","LU1366333091.USD","LU0417517546.SGD","LU1571399168.USD","IE00BK4W5L77.USD","IE00B1BXHZ80.USD","LU1201861249.SGD","GMG.AU","LU0170899867.USD","BK7068","BK7501","DDR.AU","BK4581","LU0980610538.SGD","LU0234572021.USD","LU0130102774.USD","IE00B775SV38.USD","BK4534","LU0256863811.USD","LU0154236417.USD","BK4585","BK7016","BRK.B","BK7042","LU0640476718.USD","LU0251131958.USD","IE00B3S45H60.SGD","IE00BWXC8680.SGD","COH.AU","LU0742534661.SGD","LU0234570918.USD","LU0048573561.USD","TLS.AU","RMD.AU","LU1280957306.USD","LU1363072403.SGD","TNE.AU","LU0787776722.HKD","LU0971096721.USD","BK7021","IE00B1XK9C88.USD","BK7511","LU0157215616.USD","AX1.AU","LU1914381329.SGD","LU0251142724.SGD","BK4533","BK4588"],"gpt_icon":1},{"id":"2519504668","title":"The Zacks Analyst Blog Highlights NVIDIA, Resmed, GE HealthCare and Medtronic","url":"https://stock-news.laohu8.com/highlight/detail?id=2519504668","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519504668?lang=en_us&edition=fundamental","pubTime":"2025-03-13 22:35","pubTimestamp":1741876500,"startTime":"0","endTime":"0","summary":"Chicago, IL – March 13, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: NVIDIA NVDA, Resmed RMD, GE HealthCare GEHC and Medtronic MDT.NVIDIA AI Speeds Up MedTech's Digital Boom: 3 Stocks in Focus. The medical device industry is undergoing a profound change in 2025, driven by advancements in generative AI and agentic AI. At the forefront of this revolution are players like NVIDIA, whose AI computing platforms are accelerating AI-powered medical applications and capturing investors' attention.NVIDIA's Clara platform, powered by generative AI, is enabling real-time medical imaging enhancements and predictive diagnostics. Additionally, NVIDIA's BioNeMo, a generative AI model tailored for life sciences, is advancing drug discovery and biomarker identification, directly impacting the development o","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zacks-analyst-blog-highlights-nvidia-143500365.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["GE","3NVD.UK","LU0861579265.USD","NVDS.UK","LU2430703095.HKD","LU2250418816.HKD","GEHC","NVDU","LU2168564222.USD","LU2089284900.SGD","LU1116320737.USD","NVDA","LU1066051811.HKD","LU1670627923.USD","RMD","SG9999014906.USD","LU2357305700.SGD","LU1059921491.USD","LU0496365809.HKD","LU0128525929.USD","LU2362540622.SGD","LU1861215975.USD","LU0444971666.USD","2NVD.UK","LU2362541513.USD","IE00BMPRXN33.USD","LU0528227936.USD","RMD.AU","SNVD.UK","NVD2.UK","LU0053666078.USD","NVD3.UK","BK4602","SGXZ23171101.USD","NVDS","LU0640476718.USD","LU2552382132.HKD","LU1988902786.USD","LU1496350171.SGD","LU1221951046.USD","LU2491049909.HKD","MDT","LU0868494617.USD","NVDD","NVDY","NVIW.SI"],"gpt_icon":1},{"id":"2519840071","title":"The ASX growth companies primed for a big year","url":"https://stock-news.laohu8.com/highlight/detail?id=2519840071","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519840071?lang=en_us&edition=fundamental","pubTime":"2025-03-13 13:11","pubTimestamp":1741842683,"startTime":"0","endTime":"0","summary":"First Sentier Investors’ David Wilsonand  Christian Guerra unpack why 2025 has opened to one of the most volatile reporting seasons in years. Discussing healthcare, financials, consumer and industrial names, they share their take on some surprising market disappointments – and the stocks they are excited about as growth investors.As some of you may recall, David manages one of Australia's largest and longest running geared Australian share strategies. Christian is the head of research for the Australian Equities Growth team –one of Australia's largest investment teams. Welcome both to you, David and Christian.So, David and Christian, to kick off this conversation, my first question is how many reporting seasons have you covered together now as a team?So firstly, overall earnings beat expectations. So, earnings beat by about two percentage points and that was really driven by better margins. Again, showing how corporate Australia when they need to can manage their costs. And we thought ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/the-asx-growth-companies-primed-for-a-big-year","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/the-asx-growth-companies-primed-for-a-big-year","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["PME.AU","BK7067","JBH.AU","WES.AU","XKO.AU","BK7044","BK7508","WTC.AU","CSL.AU","ARB.AU","BK7001","BK7002","QBE.AU","BK7007","HVN.AU","XJO.AU","BEN.AU","BK7501","WBC.AU","BK7064","BXB.AU","BK7078","BK7153","BK7503","CAR.AU","COL.AU","BK7082","GMG.AU","BK7135","RMD.AU","XRO.AU","COH.AU","BK7094","BK7510","BK7041","JHX.AU","BK7040","BK7155","REA.AU","XAO.AU","BK7511","NAB.AU","ALL.AU","BK7016","SUN.AU","BK7034","BK7099","BK7051","CBA.AU","BK7139"],"gpt_icon":0},{"id":"2518052884","title":"Should you buy this top ASX share in the dip?","url":"https://stock-news.laohu8.com/highlight/detail?id=2518052884","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518052884?lang=en_us&edition=fundamental","pubTime":"2025-03-12 12:41","pubTimestamp":1741754490,"startTime":"0","endTime":"0","summary":"ResMed enjoys a market-leading position, and the company does not intend to rest on its laurels. The company has pledged to continue on its path of innovation, stating it will invest 6% to 7% of its revenues into research and development to drive long-term success. I also like its exposure to the wearable devices megatrend, with ResMed set to benefit from its collaborations with tech giants Apple and Samsung. As the company has previously stated, it is well aware of its opportunity to capitalise as other tech companies follow Samsung and Apple and implement capabilities for detecting sleeping disorders such as sleep apnea. With heightened awareness of their sleeping disorders, consumers are likely to seek solutions and, in doing so, look to ResMed, the market leader in the space. These are just a few reasons why I think ResMed looks like a buy.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/03/12/should-you-buy-this-top-asx-share-in-the-dip/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["RMD.AU","BK7007","BK7501"],"gpt_icon":1},{"id":"2518803516","title":"Resmed to Consolidate Portfolio into One Brand; Shares Fall 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518803516","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518803516?lang=en_us&edition=fundamental","pubTime":"2025-03-12 12:32","pubTimestamp":1741753955,"startTime":"0","endTime":"0","summary":"Resmed  plans to consolidate its brand portfolio over the next couple of years, the company said in a statement Tuesday.The initiative will include an education program for primary care physicians to promote early sleep apnea diagnosis and a sleep health awareness push in Asia Pacific and Europe, the company said.Resmed's shares fell past 5% in recent Wednesday trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4548","LU2177674079.SGD","BK4588","BK4504","BK4082","BK4567","BK7007","BK7501","RMD","LU2008162690.USD","RMD.AU","BK4585"],"gpt_icon":0},{"id":"2518081018","title":"These top ASX shares could rise 35% to 70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518081018","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518081018?lang=en_us&edition=fundamental","pubTime":"2025-03-12 10:23","pubTimestamp":1741746209,"startTime":"0","endTime":"0","summary":"If you are looking for big potential returns (who isn't?), then it could be worth checking out the ASX shares in this article. That's because they are being tipped to rise between 35% and 70% over the next 12 months. Here's what you need to know about them: Light & Wonder Inc.  The team at Morgans sees a lot of value in this gaming technology company's shares. In response to its recent full year results release, the broker has retained its add rating with an improved price target of $220.00. This implies potential upside of over 35% for investors from current levels. Morgans believes the company's strong form can continue. It said:  Light & Wonder delivered another impressive result despite the litigation headwinds. Much of the heavy lifting was done by LNW's land-based division, with strong international outright sales and a net addition of 853 units qoq in North American gaming ops. […","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/03/12/these-top-asx-shares-could-rise-35-to-70/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["LNW.AU","BK7062","BK7007","RPL.AU","BK7501","BK7078","RMD.AU"],"gpt_icon":0},{"id":"2518670072","title":"BUZZ-Resmed's Australian shares fall after insider Ghoshal sells stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2518670072","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518670072?lang=en_us&edition=fundamental","pubTime":"2025-03-12 09:00","pubTimestamp":1741741256,"startTime":"0","endTime":"0","summary":"BUZZ-Resmed's Australian shares fall after insider Ghoshal sells stock** Resmed's Australia-listed shares RMD.AX RMD.N fall 7.7% to A$34.65, on track for their weakest trading session since June 24, 2024** Stock of healthcare technology co hits lowest level since October 8, 2024** Shares fall after company insider Kaushik Ghoshal sells company stock worth $2.33 million** Stock down 3.6% YTD  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250312:nL4N3PV01U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4567","BK4585","LU2177674079.SGD","BK7501","BK7007","BK4082","RMD.AU","BK4548","BK4504","RMD","BK4588","LU2008162690.USD"],"gpt_icon":0},{"id":"2518086009","title":"Why Breville, Flight Centre, Orica, and ResMed shares are dropping today","url":"https://stock-news.laohu8.com/highlight/detail?id=2518086009","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518086009?lang=en_us&edition=fundamental","pubTime":"2025-03-12 08:48","pubTimestamp":1741740531,"startTime":"0","endTime":"0","summary":"TheS&P/ASX 200 Index (ASX: XJO) is having another difficult session. At the time of writing, the benchmark index is down 1.6% to 7,765.3 points. Four ASX shares that are falling more than most today a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/03/12/why-breville-flight-centre-orica-and-resmed-shares-are-dropping-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["LU0128525689.USD","BK7007","ORI.AU","IE00BFMHRM44.USD","BK7070","BK4504","BK4500","RMD.AU","BK7501","BK4585","DAL","LU1267930227.SGD","LU0052756011.USD","LU0310800965.SGD","BK4008","BK7017","BRG.AU","RMD","BK4588","BK4082","FLT.AU","BK4567","BK7119","LU2177674079.SGD","BK4548","XJO.AU","LU2008162690.USD"],"gpt_icon":1},{"id":"2518030167","title":"Resmed Chief Commercial Officer Offloads $2.3 Million Worth of Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2518030167","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518030167?lang=en_us&edition=fundamental","pubTime":"2025-03-12 06:26","pubTimestamp":1741731997,"startTime":"0","endTime":"0","summary":"Resmed  Chief Commercial Officer Ghoshal Kaushik sold 9,745 of his shares in the company on the New York Stock Exchange, with an aggregate market value of $2.3 million, according to a Wednesday filing with the Australian bourse.Following the transaction, Kaushik owns nearly 146.9 million shares and other units outstanding in the company, per the filing.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4082","XKO.AU","RMD","RMD.AU","BK4567","BK7501","BK7007","BK4504","LU2177674079.SGD","LU2008162690.USD","XJO.AU","XAO.AU","BK4585","BK4548","BK4588"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RMD.AU\",params:#limit:5,,,undefined,":[{"date":"2025-05-07","symbol":"RMD.AU","amount":0.053,"announcedDate":"2025-04-24","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-05-08","defaultRemindTime":1746576000000,"name":"Resmed DRC","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-12","payableDate":"2025-05-08","currency":"USD","dateTimestamp":1746540000000,"payDate":"2025-06-12"},{"date":"2025-02-12","symbol":"RMD.AU","amount":0.053,"announcedDate":"2025-01-31","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-02-13","name":"Resmed DRC","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-20","payableDate":"2025-02-13","currency":"USD","dateTimestamp":1739278800000,"payDate":"2025-03-20"},{"date":"2024-11-06","symbol":"RMD.AU","amount":0.053,"announcedDate":"2024-10-25","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2024-11-07","name":"Resmed DRC","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-12","payableDate":"2024-11-07","currency":"USD","dateTimestamp":1730811600000,"payDate":"2024-12-12"},{"date":"2024-08-14","symbol":"RMD.AU","amount":0.053,"announcedDate":"2024-08-02","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2024-08-15","defaultRemindTime":1723593600000,"name":"Resmed DRC","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-09-19","payableDate":"2024-08-15","currency":"USD","dateTimestamp":1723557600000,"payDate":"2024-09-19"},{"date":"2024-05-08","symbol":"RMD.AU","amount":0.048,"announcedDate":"2024-04-26","type":"dividend","market":"AU","newRecordDate":"2024-05-09","defaultRemindTime":1715126400000,"name":"Resmed DRC","recordDate":"2024-06-13","payableDate":"2024-05-09","currency":"USD","dateTimestamp":1715090400000,"payDate":"2024-06-13"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RMD.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-08-19","recordDate":"2020-08-20","paymentDate":"2020-09-24","value":0.039,"currency":"USD"},{"executeDate":"2020-11-11","recordDate":"2020-11-12","paymentDate":"2020-12-17","value":0.039,"currency":"USD"},{"executeDate":"2021-02-10","recordDate":"2021-02-11","paymentDate":"2021-03-18","value":0.039,"currency":"USD"},{"executeDate":"2021-05-12","recordDate":"2021-05-13","paymentDate":"2021-06-17","value":0.039,"currency":"USD"},{"executeDate":"2021-08-18","recordDate":"2021-08-19","paymentDate":"2021-09-23","value":0.042,"currency":"USD"}]}}